Logo Image

Biosimilars

Latest News

August 30th 2012
Generic Market Overview: Standing at the Top of the Patent Cliff

The generic marketplace remains dynamic and complicated, as patent expirations,interest in biosimilars, and international competition spur major changes.

July 3rd 2012

The ACA Ruling: What it Means for Specialty Pharmacy

June 6th 2012

GPhA Commends House Approval of Historic User Fee Proposals

June 1st 2012

Health Plan Providers Interested in Managing Specialty Costs, Report Finds

April 5th 2012

Optimization of Biopharmaceuticals

Managed Care Biologics and Injectables

ByLee Goldberg,Tracey Ryan

Payer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.